A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events

A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events

The Pharmacogenomics Journal advance online publication, July 11 2017.
doi:10.1038/tpj.2017.33

Authors: M E Moretti, D F Lato, H Berger, G Koren, S Ito & W J Ungar

Source: The Pharmacogenomics Journal - July 11, 2017 Category: Drugs & Pharmacology Authors: M E Moretti D F Lato H Berger G Koren S Ito W J Ungar Source Type: research